Creutzfeldt-Jacob disease presenting as severe depression: a case report by Cumbler, Ethan et al.
BioMed  Central
Page 1 of 3
(page number not for citation purposes)
Cases Journal
Open Access Case Report
Creutzfeldt-Jacob disease presenting as severe depression: a case 
report
Ethan Cumbler*, Kristin Furfari and Jeannette Guerrasio
Address: Division of General Internal Medicine, Department of Medicine, University of Colorado Denver School of Medicine, Hospital Medicine 
Service, F782, Colorado, USA
Email: Ethan Cumbler* - Ethan.Cumbler@ucdenver.edu; Kristin Furfari - Kristin.Furfari@ucdenver.edu; 
Jeannette Guerrasio - Jeannette.Guerrasio@ucdenver.edu
* Corresponding author    
Abstract
Background: An 81 year old female presented with altered mental status after new onset of
severe depression and suicidal ideation with recent psychiatric hospitalization.
Case presentation: Key clinical features included muscle rigidity, prominent startle reflex, and
rapidly progressing cognitive decline. Initial working hypothesis was serotonin syndrome or
neuroleptic malignant syndrome but continued deterioration after medication removal prompted
evaluation for alternative etiology. Work-up revealed elevated 14-3-3 CSF protein which suggested
the prion disorder which was confirmed on post-mortem examination of brain tissue.
Conclusion:  While the degree of depression was unusually severe, the case highlights the
behavioral and psychiatric manifestations which frequently accompany Creutzfeldt-Jacob disease.
Case study
81 y/o previously highly functioning white female was
admitted for altered mental status. Recent history was sig-
nificant for development of new severe depression with
suicidal ideation, attributed to psychosocial stressors, one
month prior to presentation. During an initial 2.5 week
inpatient psychiatric hospitalization, she was treated with
venlafaxine and quetiapine with apparent initial
response. Soon after discharge from the psychiatric hospi-
tal the patient was readmitted with rapidly worsening
confusion, decreased p.o. intake, and "catatonic" behav-
ior.
Past history was significant for waldenstroms macroglob-
ulinemia. She lived alone in rural Colorado and engaged
in extensive international travel most recently to scuba
dive off the Great Barrier Reef at the age of 80.
Physical exam was significant for non-oriented female
with flat affect who followed simple commands but with-
out spontaneous speech. Her musculoskeletal exam
revealed 5/5 strength with lower extremity rigidity and a
startle response to touch.
Initial hypothesis was an adverse drug event such as neu-
roleptic malignant syndrome or serotonin syndrome. Dif-
ferential diagnosis included catatonic depression, central
nervous system infection, hyperviscosity, or paraneoplas-
tic syndrome.
Selected testing performed included brain MRI which
demonstrated cerebral atrophy and moderate to marked
white matter abnormality, electroencephalogram with
moderate diffuse background slowing and shifting lateral
predominance, but without classic periodic sharp waves,
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and a lumbar puncture with protein of 143 mg/dl (nor-
mal range 15–45 mg/dl) and elevated 14-3-3 protein.
Over her 16 day hospitalization the patient demonstrated
a progressive loss of ability to follow commands, postur-
ing, and transient focal left sided facial droop and weak-
ness. She was transferred to hospice and died 5 days later.
Autopsy, with western blot and PCR on brain tissue, con-
firmed sporadic Creutzfeldt-Jacob Disease.
Discussion
Creutzfeldt-Jacob Disease (CJD) is a rapidly progressive
spongiform neurodegenerative disorder caused by prion
proteins. The case rate is approximately 1 per million with
an average age of onset of 60.7 years [1,2]. The latency
period can last years, but time from onset of symptoms to
death is typically less than a year [2]. Eighty five percent of
cases are due to spontaneous protein transformation or
somatic gene mutations while direct infectious transmis-
sion and familial mutations account for the remaining
cases. Commonly presenting as a rapidly progressive
dementia, CJD is characterized by cognitive changes, gait
disturbance, akinetic mutism, and myoclonis. Behavioral
changes, seen in 30% of patients at the onset and 55% of
later disease stages, are common [3].
Initial presentation as severe depression with suicidal ide-
ation prompting inpatient psychiatric hospitalization is
unusual. A review of 126 cases of CJD over a 25 year
period found six who were hospitalized for symptoms of
depression during the course of their disease [4]. Psychiat-
ric symptoms are frequently treated with antipsychotics,
anxiolytics and antidepressants but often have limited
and temporary benefit.4 Antidepressants were initiated in
22 of the 126 reviewed CJD cases with only one case doc-
umenting benefit.
Rigidity and altered mental status occurring with initia-
tion of psychiatric medications may lead to initial consid-
eration of serotonin syndrome or neuroleptic malignant
syndrome. However, in CJD elevated blood pressure and
fever would not be expected and symptoms will not
improve with removal of medications.
This case emphasizes the need to consider organic
encephalopathy in the differential diagnosis of an elderly
patient without prior psychiatric history who presents
with new-onset severe depression. When the clinical pic-
ture contains motor symptoms such as rigidity or exagger-
ated startle response along with catatonic features, CJD
should be entertained, particularly if cognitive function
quickly declines and psychiatric symptoms fail to respond
to therapy. Unfortunately, there is no effective treatment
for this uniformly lethal disorder but early consideration
and timely diagnosis can allow appropriate palliation and
reduce the stress caused by uncertain etiology on family
and caregivers.
Family perspective
Virtually overnight, my vital, vigorous, feisty mother grew
brittle, unsteady, incontinent and deeply depressed – dur-
ing the last four months of her life, she repeatedly stated
to me and others that she felt she was losing her mind.
(An accurate assessment in hindsight; one to which we
should have given more weight, since she was trained as a
nurse and was the wife of a doctor, closely engaged with
the medical profession for 64 years) This was a shocking
change in our mother, since she was previously mentally
and physically active; driving, volunteering as an R.N. for
the Red Cross, travelling abroad, and avidly engaging the
world around her.
Initially, many of her symptoms were dismissed or mini-
mally explained – mobility/bladder control issues as age-
related, depression as situational, rigidity/affect flatness as
drug reaction, etc. It was frightening. Her decline – physi-
cal, cognitive and emotional – was dramatic. She lost con-
trol of thought processes and mood, was increasingly
unstable on her feet, and her personality faded. Most dis-
turbing was the seeming inability of medical profession-
als, until admission to University of Colorado Hospital, to
fully appreciate the precipitous and pronounced changes
we were observing that seemed to us to be atypical of age-
related decline, different from situational depression, and
certainly more long lasting than a possible drug reaction.
These early explanations were, to family and friends,
improbable, and our frustration grew as every day we lost
another part of the woman who had filled up our lives
with exuberance, curiosity and passion. We felt there was
a disconnect in the medical analysis, looking at a seem-
ingly random menu of diagnoses ranging from psychiat-
ric, to geriatric, to urologic, to neurologic. An earlier
consideration of the possibility of Prion disease would
have given us a rational, and therefore at least understand-
able, explanation for her decline and death.
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